National Research Corporation (NRC): Price and Financial Metrics


National Research Corporation (NRC): $44.39

0.22 (+0.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NRC POWR Grades


  • Quality is the dimension where NRC ranks best; there it ranks ahead of 98.79% of US stocks.
  • The strongest trend for NRC is in Growth, which has been heading down over the past 31 weeks.
  • NRC ranks lowest in Value; there it ranks in the 21st percentile.

NRC Stock Summary

  • The price/operating cash flow metric for National Research Corp is higher than 75.25% of stocks in our set with a positive cash flow.
  • NRC's price/sales ratio is 8.46; that's higher than the P/S ratio of 78.55% of US stocks.
  • The volatility of National Research Corp's share price is greater than that of only 6.7% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to National Research Corp, a group of peers worth examining would be LBAI, MFNC, JKHY, DOV, and SIBN.
  • NRC's SEC filings can be seen here. And to visit National Research Corp's official web site, go to nrchealth.com.

NRC Stock Price Chart Interactive Chart >

Price chart for NRC

NRC Price/Volume Stats

Current price $44.39 52-week high $60.62
Prev. close $44.17 52-week low $42.41
Day low $43.67 Volume 48,700
Day high $44.79 Avg. volume 36,585
50-day MA $48.20 Dividend yield 1.08%
200-day MA $49.83 Market Cap 1.13B

National Research Corporation (NRC) Company Bio


National Research Corporation provides ongoing survey-based performance measurement, analysis, and tracking services to the healthcare industry. The Company addresses the need of healthcare providers and payers to measure the care outcomes, specifically satisfaction, and health status of patients and members.

NRC Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$44.39$21.12 -58%

Below please find a table outlining a discounted cash flow forecast for NRC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that National Research Corp ranked in the 32th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for NRC, they are:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 98. Notably, its equity weight is greater than 83.55% of US equities in the Healthcare sector yielding a positive free cash flow.
  • The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than just 11.18% of the free cash flow producing stocks we're observing.
  • NRC's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 52.98% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-59%
1%-59%
2%-58%
3%-58%
4%-58%
5%-57%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as NRC, try GMED, NVS, CRL, DHR, and DXCM.


NRC Latest News Stream


Event/Time News Detail
Loading, please wait...

NRC Latest Social Stream


Loading social stream, please wait...

View Full NRC Social Stream

Latest NRC News From Around the Web

Below are the latest news stories about National Research Corp that investors may wish to consider to help them evaluate NRC as an investment opportunity.

National Research Corporation Declares Quarterly Dividend

Lincoln, Nebraska, June 09, 2021 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Thursday, July 15, 2021, to shareholders of record as of the close of business on Wednesday, June 30, 2021. For more than 40 years, National Research Corporation has been a leading provider of analytics and insights that facilitate measurement and improvement of human understand

Yahoo | June 9, 2021

Investors Shouldn't Overlook National Research's (NASDAQ:NRC) Impressive Returns On Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Yahoo | June 2, 2021

National Research Corporation Announces First Quarter 2021 Results

LINCOLN, Neb., May 04, 2021 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRC) today announced results for the first quarter of 2021. As we emerge from the impact of COVID-19, our focus continues on increasing revenue growth rate and enabling human understanding for the clients we serve. Our primary emphasis is on our organic growth levers of increasing revenue from our core offerings within our existing client base, as well as adding new clients to increase market share. As a result, revenue from our Voice of the Customer offerings increased by 19% in the first quarter of 2021 compared to 2020, and we continued our momentum of winning new clients, including Wake Forest Baptist Health, San Francisco Health Network and UC San Diego Health. In the first quarter we also execut...

Yahoo | May 4, 2021

If You Like EPS Growth Then Check Out National Research (NASDAQ:NRC) Before It's Too Late

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...

Yahoo | May 3, 2021

National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Yahoo | April 2, 2021

Read More 'NRC' Stories Here

NRC Price Returns

1-mo -9.52%
3-mo -13.30%
6-mo -6.41%
1-year -16.52%
3-year 25.01%
5-year 270.57%
YTD 4.10%
2020 -34.84%
2019 75.47%
2018 5.40%
2017 99.10%
2016 21.08%

NRC Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full NRC Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8941 seconds.